...
search icon
cstl-img

Castle Biosciences Inc Share Price

CSTL
NMQ
$33.42
+$0.27
(0.81%)
1D
Industry: Biotechnology Sector: Health Care

Castle Biosciences Inc Analyst Forecast

Castle Biosciences Inc Share Price Chart

Castle Biosciences Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$967.60M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
231.54K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.05
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$14.59 L
$44.28 H
$33.42

About Castle Biosciences Inc, Common Stock

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a risk stratification spatial-omics test to predict future development of progression of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide optimal drug treatment for patients diagnosed with major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. The company offers its products to skin cancer and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas. more

Industry: BiotechnologySector: Health Care

Castle Biosciences Inc Stock Returns

Time FrameCSTLSectorS&P500
1-Week Return3.24%1.51%-1.5%
1-Month Return-18.21%1.46%0.6%
3-Month Return-1.56%3.94%2.43%
6-Month Return62.55%16.03%6.01%
1-Year Return25.07%9.1%11.48%
3-Year Return28.54%19.46%67.52%
5-Year Return-62.94%35.29%73.75%
10-Year Return56.17%137.42%254.46%

Castle Biosciences Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue62.65M94.08M137.04M219.79M332.07M[{"date":"2020-12-31","value":18.87,"profit":true},{"date":"2021-12-31","value":28.33,"profit":true},{"date":"2022-12-31","value":41.27,"profit":true},{"date":"2023-12-31","value":66.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue9.69M15.82M32.01M44.98M60.20M[{"date":"2020-12-31","value":16.09,"profit":true},{"date":"2021-12-31","value":26.28,"profit":true},{"date":"2022-12-31","value":53.17,"profit":true},{"date":"2023-12-31","value":74.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit52.96M78.26M105.03M174.81M271.86M[{"date":"2020-12-31","value":19.48,"profit":true},{"date":"2021-12-31","value":28.79,"profit":true},{"date":"2022-12-31","value":38.63,"profit":true},{"date":"2023-12-31","value":64.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin84.54%83.18%76.64%79.53%81.87%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.39,"profit":true},{"date":"2022-12-31","value":90.66,"profit":true},{"date":"2023-12-31","value":94.08,"profit":true},{"date":"2024-12-31","value":96.84,"profit":true}]
Operating Expenses59.51M118.34M177.88M242.78M263.19M[{"date":"2020-12-31","value":22.61,"profit":true},{"date":"2021-12-31","value":44.96,"profit":true},{"date":"2022-12-31","value":67.59,"profit":true},{"date":"2023-12-31","value":92.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(6.54M)(40.08M)(72.86M)(67.98M)8.67M[{"date":"2020-12-31","value":-75.46,"profit":false},{"date":"2021-12-31","value":-462.27,"profit":false},{"date":"2022-12-31","value":-840.31,"profit":false},{"date":"2023-12-31","value":-784.05,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(5.92M)134.00K7.90M20.38M25.23M[{"date":"2020-12-31","value":-23.46,"profit":false},{"date":"2021-12-31","value":0.53,"profit":true},{"date":"2022-12-31","value":31.32,"profit":true},{"date":"2023-12-31","value":80.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(10.20M)(40.01M)(68.90M)(57.37M)21.56M[{"date":"2020-12-31","value":-47.3,"profit":false},{"date":"2021-12-31","value":-185.55,"profit":false},{"date":"2022-12-31","value":-319.53,"profit":false},{"date":"2023-12-31","value":-266.02,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes84.00K(8.72M)(1.77M)101.00K3.32M[{"date":"2020-12-31","value":2.53,"profit":true},{"date":"2021-12-31","value":-262.73,"profit":false},{"date":"2022-12-31","value":-53.21,"profit":false},{"date":"2023-12-31","value":3.04,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(10.28M)(31.29M)(67.14M)(57.47M)18.25M[{"date":"2020-12-31","value":-56.37,"profit":false},{"date":"2021-12-31","value":-171.51,"profit":false},{"date":"2022-12-31","value":-367.98,"profit":false},{"date":"2023-12-31","value":-314.97,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations(10.28M)(31.29M)(67.14M)(75.50M)18.25M[{"date":"2020-12-31","value":-56.37,"profit":false},{"date":"2021-12-31","value":-171.51,"profit":false},{"date":"2022-12-31","value":-367.98,"profit":false},{"date":"2023-12-31","value":-413.83,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(10.28M)(31.29M)(67.14M)(57.47M)18.25M[{"date":"2020-12-31","value":-56.37,"profit":false},{"date":"2021-12-31","value":-171.51,"profit":false},{"date":"2022-12-31","value":-367.98,"profit":false},{"date":"2023-12-31","value":-314.97,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(0.56)(1.23)(2.58)(2.16)0.62[{"date":"2020-12-31","value":-90.32,"profit":false},{"date":"2021-12-31","value":-198.39,"profit":false},{"date":"2022-12-31","value":-416.13,"profit":false},{"date":"2023-12-31","value":-348.39,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Castle Biosciences Inc Ratios

Castle Biosciences Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

CSTL
Cash Ratio 5.20
Current Ratio 6.47
Quick Ratio 6.31

Castle Biosciences Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CSTL
ROA (LTM) -1.72%
ROE (LTM) -2.70%

Castle Biosciences Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CSTL
Debt Ratio Lower is generally better. Negative is bad. 0.17
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.83

Castle Biosciences Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CSTL
Trailing PE NM
Forward PE NM
P/S (TTM) 2.82
P/B 2.07
Price/FCF 124
EV/R 2.09
EV/Ebitda 29.88

FAQs

What is Castle Biosciences Inc share price today?

Castle Biosciences Inc (CSTL) share price today is $33.42

Can Indians buy Castle Biosciences Inc shares?

Yes, Indians can buy shares of Castle Biosciences Inc (CSTL) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CSTL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Castle Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Castle Biosciences Inc (CSTL) via the Vested app. You can start investing in Castle Biosciences Inc (CSTL) with a minimum investment of $1.

How to invest in Castle Biosciences Inc shares from India?

You can invest in shares of Castle Biosciences Inc (CSTL) via Vested in three simple steps:

  • Click on Sign Up or Invest in CSTL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Castle Biosciences Inc shares
What is Castle Biosciences Inc 52-week high and low stock price?

The 52-week high price of Castle Biosciences Inc (CSTL) is $44.28. The 52-week low price of Castle Biosciences Inc (CSTL) is $14.59.

What is Castle Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Castle Biosciences Inc (CSTL) is

What is Castle Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Castle Biosciences Inc (CSTL) is 2.07

What is Castle Biosciences Inc dividend yield?

The dividend yield of Castle Biosciences Inc (CSTL) is 0.00%

What is the Market Cap of Castle Biosciences Inc?

The market capitalization of Castle Biosciences Inc (CSTL) is $967.60M

What is Castle Biosciences Inc's stock symbol?

The stock symbol (or ticker) of Castle Biosciences Inc is CSTL

How Can Investors Use Castle Biosciences Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Castle Biosciences Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Castle Biosciences Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Castle Biosciences Inc shares for Indian investors?

When investing in Castle Biosciences Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Castle Biosciences Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Castle Biosciences Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Castle Biosciences Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Castle Biosciences Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top